Top compounds associated with response to SLC22A31


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA austocystin d CTRPv2 pan-cancer AAC 0.11 0.003
mRNA lapatinib CCLE pan-cancer AAC 0.12 0.005
mRNA barasertib CTRPv2 pan-cancer AAC -0.09 0.005
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.098 0.005
mRNA decitabine CTRPv2 pan-cancer AAC -0.076 0.005
mRNA AT7867 CTRPv2 pan-cancer AAC -0.096 0.006
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.007
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.1 0.007
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.094 0.007
Download CSV